Adverse Reaction to Drug
18
0
0
7
Key Insights
Highlights
Success Rate
78% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
11.1%
2 terminated out of 18 trials
77.8%
-8.7% vs benchmark
17%
3 trials in Phase 3/4
57%
4 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (18)
Exploratory Propofol Dose Finding Study In Neonates
Efficacy and Safety of Sertraline in the Treatment of Maintenance Hemodialysis Patients With Depression
Intensive Monitoring Scheme of Lidocaine Cataplasms
Clinical Analysis of Safety in Latent Tuberculosis Infection Prophylaxis Treatment
The Use of Midazolam and Remifentanil During Dialysis Access Procedures
Cells of Monocytic Origin as Surrogate Markers for Individual Drug Effects and Hepatotoxicity
Assessment of Immediate Adverse Reactions From Dotarem in Children Under 2 Years of Age
Personal Health Records and Elder Medication Use Quality
Post-operative Pain Control After Pediatric Adenotonsillectomy
Post-market Safety Reassessment of Ulinastatin for Injection
The Thai Surgical Intensive Care Study (Thai-SICU Study)
Oral Thalidomide and Tegafur-uracil to Decrease Hepatocellular Carcinoma Recurrence
Determining the Impact of a Medication Delivery Unit on Medication Adherence of Adults With Common Cardiac Conditions
Development of Escitalopram Genomic Device by Using Candidate Gene Approach and Genome-Wide Scanning
Development of A Technique to Predict Antidepressant Responsiveness in Depressive Patients
Pharmacogenomic Study to Predict Antidepressant Responsiveness in Depressed Patients
Explore Active Surveillance Mode of the Community's Adverse Event Following Immunization(AEFI)
Feasibility of Using a Telemedicine Medication Delivery Unit for Older Adults